279 related articles for article (PubMed ID: 28740260)
1. Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers.
Vesterbacka J; Rivera J; Noyan K; Parera M; Neogi U; Calle M; Paredes R; Sönnerborg A; Noguera-Julian M; Nowak P
Sci Rep; 2017 Jul; 7(1):6269. PubMed ID: 28740260
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiome Profiles and Associated Metabolic Pathways in HIV-Infected Treatment-Naïve Patients.
do Nascimento WM; Machiavelli A; Ferreira LGE; Cruz Silveira L; de Azevedo SSD; Bello G; Smith DP; Mezzari MP; Petrosino JF; Delgado Duarte RT; Zárate-Bladés CR; Pinto AR
Cells; 2021 Feb; 10(2):. PubMed ID: 33668457
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.
Vujkovic-Cvijin I; Dunham RM; Iwai S; Maher MC; Albright RG; Broadhurst MJ; Hernandez RD; Lederman MM; Huang Y; Somsouk M; Deeks SG; Hunt PW; Lynch SV; McCune JM
Sci Transl Med; 2013 Jul; 5(193):193ra91. PubMed ID: 23843452
[TBL] [Abstract][Full Text] [Related]
4. Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a
Sperk M; Ambikan AT; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sönnerborg A; Neogi U
J Virol; 2021 Aug; 95(18):e0047921. PubMed ID: 34232744
[TBL] [Abstract][Full Text] [Related]
5. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.
Vázquez-Castellanos JF; Serrano-Villar S; Latorre A; Artacho A; Ferrús ML; Madrid N; Vallejo A; Sainz T; Martínez-Botas J; Ferrando-Martínez S; Vera M; Dronda F; Leal M; Del Romero J; Moreno S; Estrada V; Gosalbes MJ; Moya A
Mucosal Immunol; 2015 Jul; 8(4):760-72. PubMed ID: 25407519
[TBL] [Abstract][Full Text] [Related]
6. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.
Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Bargiela R; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Seifert J; Barbas C; Moya A; Ferrer M
EBioMedicine; 2016 Jun; 8():203-216. PubMed ID: 27428431
[TBL] [Abstract][Full Text] [Related]
7. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Linked to Sexual Preference and HIV Infection.
Noguera-Julian M; Rocafort M; Guillén Y; Rivera J; Casadellà M; Nowak P; Hildebrand F; Zeller G; Parera M; Bellido R; Rodríguez C; Carrillo J; Mothe B; Coll J; Bravo I; Estany C; Herrero C; Saz J; Sirera G; Torrela A; Navarro J; Crespo M; Brander C; Negredo E; Blanco J; Guarner F; Calle ML; Bork P; Sönnerborg A; Clotet B; Paredes R
EBioMedicine; 2016 Mar; 5():135-46. PubMed ID: 27077120
[TBL] [Abstract][Full Text] [Related]
9. Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
Li SX; Armstrong A; Neff CP; Shaffer M; Lozupone CA; Palmer BE
Clin Pharmacol Ther; 2016 Jun; 99(6):600-11. PubMed ID: 26940481
[TBL] [Abstract][Full Text] [Related]
10. Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.
Hoel H; Hove-Skovsgaard M; Hov JR; Gaardbo JC; Holm K; Kummen M; Rudi K; Nwosu F; Valeur J; Gelpi M; Seljeflot I; Ueland PM; Gerstoft J; Ullum H; Aukrust P; Nielsen SD; Trøseid M
Sci Rep; 2018 Apr; 8(1):6725. PubMed ID: 29712976
[TBL] [Abstract][Full Text] [Related]
11. HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases.
Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Margolles A; Seifert J; Barbas C; Moya A; Ferrer M
Sci Rep; 2016 May; 6():26192. PubMed ID: 27189771
[TBL] [Abstract][Full Text] [Related]
12. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection.
Moon JY; Zolnik CP; Wang Z; Qiu Y; Usyk M; Wang T; Kizer JR; Landay AL; Kurland IJ; Anastos K; Kaplan RC; Burk RD; Qi Q
EBioMedicine; 2018 Nov; 37():392-400. PubMed ID: 30366816
[TBL] [Abstract][Full Text] [Related]
14. Elite controllers microbiome: unraveling the mystery of association and causation.
Bai X; Sönnerborg A; Nowak P
Curr Opin HIV AIDS; 2024 Jun; ():. PubMed ID: 38874425
[TBL] [Abstract][Full Text] [Related]
15. The microbiome and HIV persistence: implications for viral remission and cure.
Koay WLA; Siems LV; Persaud D
Curr Opin HIV AIDS; 2018 Jan; 13(1):61-68. PubMed ID: 29135490
[TBL] [Abstract][Full Text] [Related]
16. Fecal bacterial microbiome diversity in chronic HIV-infected patients in China.
Sun Y; Ma Y; Lin P; Tang YW; Yang L; Shen Y; Zhang R; Liu L; Cheng J; Shao J; Qi T; Tang Y; Cai R; Guan L; Luo B; Sun M; Li B; Pei Z; Lu H
Emerg Microbes Infect; 2016 Apr; 5(4):e31. PubMed ID: 27048741
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
18. Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell count.
Ji Y; Zhang F; Zhang R; Shen Y; Liu L; Wang J; Yang J; Tang Q; Xun J; Qi T; Wang Z; Song W; Tang Y; Chen J; Lu H
Emerg Microbes Infect; 2018 Jun; 7(1):113. PubMed ID: 29934497
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
20. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
